# Stryker acquires 95.5% of Vexim, plans squeeze-out

Stryker acquired approximately 95.5% of the share capital of French spinal implant maker Vexim and plans a public buy-out offer and squeeze-out for the remaining shares at about $24.88 per share, expected in Q2 2018.

- Type: Acquisition
- Announced: 2018-02-14
- Where: near Toulouse, France, France
- Value: $216.0M
- Status: announced
- Products: spinal implants, SpineJack implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (acquirer)
- [VEXIM](https://endata.com/companies/27500.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/stryker-nears-closure-vexim-takeover-passes-95-ownership/), 2018-02-14: "Stryker said it has acquired approximately 95.5% of the share capital of French spinal implant maker Vexim, and that it plans to acquire the remaining shares soon."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
